174 related articles for article (PubMed ID: 24903673)
21. Claudin 6 expression is useful to distinguish myxofibrosarcomas from other myxoid soft tissue tumors.
Bekki H; Yamamoto H; Takizawa K; Iwasaki T; Otsuka H; Yamada Y; Kohashi K; Harimaya K; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):674-679. PubMed ID: 28476380
[TBL] [Abstract][Full Text] [Related]
22. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
Sarrió D; Rodriguez-Pinilla SM; Hardisson D; Cano A; Moreno-Bueno G; Palacios J
Cancer Res; 2008 Feb; 68(4):989-97. PubMed ID: 18281472
[TBL] [Abstract][Full Text] [Related]
23. Metastasizing basal cell carcinoma: A clinicopathologic and immunohistochemical study of 22 cases.
Mochel MC; Liaquat S; Moore JB; Hoang MP
J Cutan Pathol; 2021 Mar; 48(3):374-383. PubMed ID: 33010047
[TBL] [Abstract][Full Text] [Related]
24. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
25. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.
Dunlap SM; Chiao LJ; Nogueira L; Usary J; Perou CM; Varticovski L; Hursting SD
Cancer Prev Res (Phila); 2012 Jul; 5(7):930-42. PubMed ID: 22588949
[TBL] [Abstract][Full Text] [Related]
26. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Vellon L; Menendez JA
Cell Cycle; 2011 Nov; 10(22):3871-85. PubMed ID: 22127234
[TBL] [Abstract][Full Text] [Related]
27. Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients.
Adem C; Reynolds C; Adlakha H; Roche PC; Nascimento AG
Histopathology; 2002 Jun; 40(6):556-62. PubMed ID: 12047767
[TBL] [Abstract][Full Text] [Related]
28. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
29. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
30. [Low-grade (fibromatosis-like) spindle cell carcinoma of the breast: case report and review of the literature].
Tang F; Gu DH; Bao Y; Wang H; Zhu HG; Xu ZD; Hu XQ
Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):444-5. PubMed ID: 16251060
[No Abstract] [Full Text] [Related]
31. Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguous.
Takano EA; Hunter SM; Campbell IG; Fox SB
J Clin Pathol; 2015 May; 68(5):362-7. PubMed ID: 25713418
[TBL] [Abstract][Full Text] [Related]
32. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
[TBL] [Abstract][Full Text] [Related]
33. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
[TBL] [Abstract][Full Text] [Related]
34. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
35. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
[TBL] [Abstract][Full Text] [Related]
37. Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype.
Jeong H; Ryu YJ; An J; Lee Y; Kim A
Histopathology; 2012 May; 60(6B):E87-95. PubMed ID: 22439911
[TBL] [Abstract][Full Text] [Related]
38. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM; Poryazova-Markova EG
Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
[TBL] [Abstract][Full Text] [Related]
39. Metaplastic breast carcinoma: pathology and clinical outcome.
Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
[TBL] [Abstract][Full Text] [Related]
40. Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impact.
Voutilainen S; Heikkilä P; Sampo M; Nevanlinna H; Blomqvist C; Mattson J
Acta Oncol; 2021 Sep; 60(9):1233-1239. PubMed ID: 34282709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
